Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04136951 · ClinicalTrials.gov registry record · NA
Improving Patient Prioritization During Hospital-homecare Transition
A NA study of Diabetes Mellitus, Type 2 and Congestive Heart Failure, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 1,915
- Enrollment target
- 2
- Study locations
NCT04136951: Completed NA study of Diabetes Mellitus, Type 2 and Congestive Heart Failure, sponsored by Columbia University.
NCT04136951 is a NA study of Diabetes Mellitus, Type 2 and Congestive Heart Failure that has completed, run by Columbia University. The registered enrollment target is 1,915 participants, below the 4,480-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04136951, a NA study of Diabetes Mellitus, Type 2 and Congestive Heart Failure, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,915 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research work is focused on building and evaluating one of the first evidence-based clinical decision support tools for homecare in the United States. The results of this study have the potential to standardize and individualize nursing decision making using cutting-edge technology and to improve patient outcomes in the homecare setting.
Primary Outcome
To learn if using PREVENT tool results in decreased incidence of rehospitalization \[defined as recurrent hospital admission within 60 days from hospital discharge\]
Conditions Studied
Interventions
- OTHER PREVENT clinical decision support
Study Locations (2)
New York
- Columbia University School of Nursing - New York
- Visiting Nurse Service of New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,915 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2024-05-01 |
| Phase | NA |
What the finished NCT04136951 record still lists
NCT04136951 is an interventional study that assigns participants to a tested intervention. Its 1,915 participants enrollment target places it among the larger protocols in the corpus, below the 4,480-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (57% lower).
The record links to 5 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which PREVENT clinical decision support is the first listed.
NCT04136951 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04136951 about?
NCT04136951 is a clinical study titled "Improving Patient Prioritization During Hospital-homecare Transition". This research work is focused on building and evaluating one of the first evidence-based clinical decision support tools for homecare in the United States. The results of this study have the potential to standardize and individualize nursing decision making using cutting-edge technology and to impro...
What is the current status of trial NCT04136951?
This trial is currently completed. It is a NA study. The enrollment target is 1,915 participants. The study started on 2023-08-01. Estimated completion is 2024-05-01.
What conditions does trial NCT04136951 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Congestive Heart Failure, Dyspnea, Renal Failure, Obstructive Pulmonary Disease.
What interventions are being tested in trial NCT04136951?
The interventions under investigation include: PREVENT clinical decision support (OTHER).
Who is sponsoring clinical trial NCT04136951?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04136951 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04136951's enrollment target sits among peer trials
1,915 19th of 348 higher than 330 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05174169 · 1,912 participants · Phase 2
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- NCT06799117 · 1,912 participants · NA
Adaptive Decision Support for Addiction Treatment Master
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
- NCT03729180 · 1,900 participants · NA
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI